Skip to main content

DaVita Value Stock - Dividend - Research Selection

Davita

ISIN: US23918K1088 , WKN: 897914

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company operates DaVita Rx, a pharmacy that provides oral medications and medication management services to patients with ESRD; disease management services; vascular access services; clinical research programs; physician services; and direct primary care services. As of December 31, 2017, it provided dialysis and administrative services in the United States through a network of 2,510 outpatient dialysis centers serving approximately 197,800 patients; and operated 237 outpatient dialysis centers located in 11 countries outside of the United States. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was founded in 1994 and is headquartered in Denver, Colorado.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


DaVita Center Updates: Severe Winter Weather Along Gulf Coast

2025-01-21
Severe winter weather is bringing heavy snow, sleet and freezing rain to the Gulf Coast and Southeast, with widespread impact expected. DaVita's care teams across the region are...

IYH: Healthcare Dashboard For January

2025-01-20
iShares U.S. Healthcare ETF has higher fees and lower performance. See why IYH is a top choice and learn about 10 cheaper healthcare stocks this January.

DaVita Supports Thousands of Patients and Teammates Affected by Southern California Wildfires

2025-01-09
DaVita, a comprehensive kidney care provider, has activated its emergency response plan as devastating wildfires spread across Southern California. DaVita's emergency response plan includes:

DaVita Center Updates: January 2025 Wildfires

2025-01-08
A wildfire that started in one area of Los Angeles on Tuesday continues to impact a large area of the state. DaVita's care teams are focused on ensuring the safety of our patients, themselves...

DaVita HealthCare (DVA) Rises As Market Takes a Dip: Key Facts

2025-01-07
DaVita HealthCare (DVA) closed the most recent trading day at $152.69, moving +0.77% from the previous trading session.

DaVita HealthCare (DVA) Stock Dips While Market Gains: Key Facts

2025-01-06
The latest trading day saw DaVita HealthCare (DVA) settling at $151.53, representing a -0.84% change from its previous close.

Compelling Reasons for Investors to Hold on to Centene Stock

2025-01-06
CNC remains well-poised for growth on the back of an expanding customer base, improved premiums, strategic acquisitions and commendable cash reserves.

Should Value Investors Buy DaVita (DVA) Stock?

2025-01-02
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

RSP: S&P 500 Monthly Dashboard For January

2025-01-02
RSP holds the S&P 500 Index constituents in equal weight, rebalanced on a quarterly basis. Read more to see my recommendation for the fund.

DaVita HealthCare (DVA) Stock Moves -0.16%: What You Should Know

2024-12-31
DaVita HealthCare (DVA) closed at $149.55 in the latest trading session, marking a -0.16% move from the prior day.